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Anesthesiology Control Tower: Feasibility
Assessment to Support Translation
(ACT-FAST)—a feasibility study protocol
Teresa M. Murray-Torres1* , Frances Wallace2, Mara Bollini1, Michael S. Avidan1 and Mary C. Politi3,4

Abstract
Background: Major postoperative morbidity and mortality remain common despite efforts to improve patient
outcomes. Health information technologies have the potential to actualize advances in perioperative patient care,
but failure to evaluate the usability of these technologies may hinder their implementation and acceptance. This
protocol describes the usability testing of an innovative telemedicine-based intra-operative clinical support system,
the Anesthesiology Control Tower, in which a team led by an attending anesthesiologist will use a combination of
established and novel information technologies to provide evidence-based support to their colleagues in the
operating room.
Methods: Two phases of mixed-methods usability testing will be conducted in an iterative manner and will evaluate
both the individual components of the Anesthesiology Control Tower and their integration as a whole. Phase I testing
will employ two separate “think-aloud” protocol analyses with the two groups of end users. Segments will be coded
and analyzed for usability issues. Phase II will involve a qualitative and quantitative in situ usability and feasibility
analysis. Results from each phase will inform the revision and improvement of the Control Tower prototype
throughout our testing and analysis process. The final prototype will be evaluated in the form of a pragmatic
randomized controlled clinical trial.
Discussion: The Anesthesiology Control Tower has the potential to revolutionize the standard of care for
perioperative medicine. Through the thorough and iterative usability testing process described in this protocol,
we will maximize the usefulness of this novel technology for our clinicians, thus improving our ability to implement
this innovation into the model of care for perioperative medicine.
Trial registration: The study that this protocol describes has been registered in clinicaltrials.gov as NCT02830126.
Keywords: Usability, Feasibility, Telemedicine, Clinician decision support, Health information technology,
Human-computer interaction

Background
Despite major advancements in the safety of anesthetic
techniques and therapeutics, the risk of patient morbidity
and mortality related to surgery persists. Some of this risk
is unavoidable and either is inherent to the nature of the
surgical procedure itself or is attributable to a characteristic of the patient that is not in an immediate way modifiable [1–3]. There are, however, factors that do fall under
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the control of the anesthetic team that have been shown
to affect the patient’s immediate and long-term health
[4–7]. Information technology-driven decision support
has been shown to optimize management of these
factors, leading to improvement in physiological measures, such as blood pressure stability [8] and glucose
control [9, 10]. This decision support can aid members of
the anesthesia care team, who often experience information overload in the operating room that can limit their
implementation of evidence-based practice. Health IT
tools that work to advance and implement decision
support systems are being championed in the demand for

© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Murray-Torres et al. Pilot and Feasibility Studies (2018) 4:38

enhanced quality in health care [11, 12]. A critical component of the implementation process is the inclusion of
usability analysis of the health IT throughout its lifecycle,
beginning in the development phase and continuing into
the post-implementation period [13]. Usability is an essential feature of the successful implementation of novel
information technologies [14–16] and has significant
impact on productivity and performance [13] in addition
to the acceptance and safety of health IT systems [13].
At our institution, we are developing a novel
telemedicine-based intervention for the operating room,
the Anesthesiology Control Tower (ACT), which is similar in concept to an air traffic control tower for a busy
airport. The clinicians in the Anesthesiology Control
Tower (ACTors) will monitor active operating rooms
(ORs) in real time by using several electronic health records at our institution. Just as an air traffic control
tower monitors each aircraft and delivers additional
information and alerts to the pilot and co-pilot, the
ACT will engage with teams of anesthesia clinicians in a
similar fashion to assist them in providing safe, effective,
and efficient care for their patients. The ACT intervention will be evaluated in the form of a pragmatic,
comparative effectiveness randomized controlled trial
(NCT02830126). However, prior to the implementation
of the ACT, it will be crucial to ensure that it is a useful
and usable resource for the clinicians for whom it is
developed, as usability is a critical feature of the successful implementation of novel information technologies
[14–16], with a significant impact on productivity and
performance [13] in addition to the acceptance and
safety of health IT systems [13]. The primary objective
of the protocol described in this paper is to evaluate the
usability of the ACT by gathering perceptions of key
stakeholders and end users of the ACT and secondarily
to assess the feasibility of its implementation in routine
care, prior to conducting a pragmatic trial evaluating the
ACT. Usability testing will be performed in an iterative
manner throughout the design and implementation
stages and will focus on outcomes related to effectiveness,
efficiency, and acceptability. This protocol describes two
phases of mixed-methods (qualitative and quantitative)
usability and feasibility testing [15, 17–20] of the
ACT structure, including the software platforms that
it employs.

Methods
The full description of ACT is available in Appendix 1.
This includes a description of one of the software programs used in the ACT, called AlertWatch® (Ann Arbor,
MI), which is a clinical monitoring and alerting system
(Appendix 1, Figs. 1, 2 and 3). The specific and unique
platform described in this protocol, AlertWatch (AW)
Tower Mode, will be customized and refined through
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this research. While the developers of AlertWatch will
be involved in refinements of the ACT based on the
findings of our study, they will have no input on the design of the study nor how it is carried out and no involvement in the data collection and analysis process.
The initial design of the AW Tower Mode is based on
input from experts in clinical anesthesiology and medical
informatics. We anticipate that prototype revision and
improvement will occur throughout the usability testing
and analysis process.
Two phases of usability testing will be conducted in
series, as described fully below. A mixed-methods
approach of qualitative and quantitative analysis will be
employed. The first phase of testing will be an exploratory
analysis that employs a “think-aloud” approach, which is
well suited for identifying key usability issues and barriers
to adoption of new technologies [21]. It will include parallel testing with two groups of end users (Table 1). The
second phase of testing will involve in situ use of the ACT
by end users and will further focus on the outcomes of
efficiency, efficacy, and learnability of and satisfaction with
the ACT [22, 23].
Participants in this study will be recruited from the department of anesthesiology through approved use of the
departmental distribution list, which is the most common
method of communication within the department. An initial recruitment email will be sent to all the members of
each relevant participant group (Table 1). Additional study
information will be provided to any interested parties, and
those who express interest in joining the study will be
formally consented for participation.
During the study, access to data files will be strictly limited to members of the research team. All computer files
will be stored on an encrypted server, with additional
password protection for any file that contains identifying
information. Physical copies of surveys etc. will be stored
in a locked location to which only the research team has
access. All physical data files and all recordings will be
destroyed at a pre-specified time after collection.

Phase I: usability analysis with a “think-aloud” protocol
Phase Ia

Participants will be recruited via email from the groups
of clinicians who would potentially staff the ACT
(ACTors), namely, attending anesthesiologists and senior
anesthesiology residents. All attending and senior
resident anesthesiologists in the department will be
eligible to participate. Eight to ten participants are an
appropriate number to identify the majority of surfacelevel usability problems [24], and three to five participants per testing round are cost-efficient, maximizing
identification of issues while reducing redundancy [25].
A total of 12–15 participants will participate.
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Table 1 Participant groups at each stage of testing
Stage of
testing

Description

Potential Participant
Groups

Phase Ia

“Think-aloud” analysis for
physicians
staffing ACT

Attending
anesthesiologists

“Think-aloud” analysis for
clinicians receiving
ACT support

Attending
anesthesiologists

Phase
Ib

Anesthesiology
residents

Anesthesiology
residents
Certified registered
nurse anesthetists

Phase II

Mixed in situ usability and
feasibility analysis

Attending
anesthesiologists
Anesthesiology residents

Phase Ib

Participants will be recruited via email from the groups
of clinicians who are potential recipients of the ACT
support (clinicians in the OR—or CORs), namely,
attending anesthesiologists, anesthesiology residents, and
certified registered nurse anesthetists (CRNAs). A total
of 10–15 participants will be included. There will be no
overlap with participants in phase Ia, but there are no
other exclusion criteria.
Procedure

Phase Ia: “think-aloud” with ACTors Participants will
receive an orientation to the ACT and a description of
the tasks that they are to accomplish. Sessions will be
conducted by the authors in the room that houses the
ACT (TM, FW, MB); one or two authors will be present
per session without additional observers. These authors
are members of the department of anesthesiology who
do not have any supervisory roles in relation to participants in the study (resident physician, medical student,
and research staff member, respectively). These authors
will receive training on the administration of usability
testing scenarios. During the sessions, participants will
use available clinical applications to monitor active
operating rooms and address alerts generated by the
AW Tower Mode platform. Alerts are addressed by
documenting an assessment and recommended action
for each alert. Users will verbalize all thoughts, feelings,
and questions as they navigate through specific aspects
of the software programs and the ACT layout and design
to complete their tasks. The research team members will
prompt participants only if 20 s [21] or more elapses
without verbalization from the participant. Sessions will
be audio recorded. Observations and field notes from
the research team will be included to provide additional
insight. Participants will complete 20 min of testing.
This will be followed by a debriefing session that will
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employ open-ended questions to obtain feedback on
specific issues (Appendix 2). The total length of sessions
will be approximately 50–60 min.
At the end of each session, participants will complete
the NASA Task Loading Index (NASA-TLX [26–28]),
the 10-item System Usability Scale (SUS [29]), and the
19-item Computer System Usability Questionnaire
(CSUQ [30]). The SUS and the CSUQ are appropriate
for subjective ratings of usability. The SUS offers a final
score that ranges from 0 to 100, with a “passable” score
above 70 [31]. The CSUQ offers a total score ranging
from 0 to 7, in addition to three subscale scores (system
usefulness, information quality, and interface quality).
Phase Ib: “think-aloud” with CORs Sessions will take
place in a conference room on the medical campus of
the hospital complex and will be administered by one
author (TM) with a second author as an observer (FW).
Participants will be informed of the purpose and format
of the procedure and will receive an orientation to how
the ACT will function. After this, open-ended questions
will be used to prompt participants to provide their initial reactions to the ACT intervention. Subsequently, the
research team member will present clinical scenarios
that invite the participant to think about interacting with
the ACT as a recipient of the ACT support. Participants
will be instructed to imagine themselves in each scenario
and to voice all thoughts that arise as they do so. After
participants have had the opportunity to share their
thoughts freely for each scenario, a short series of openended questions (Appendix 2) will be used to obtain
COR feedback with regard to specific features of the
ACT, such as the usefulness of particular alerts and of
different methods of communication with the ACT.
Sessions will be audio recorded. Field notes and observations from the research team member will again be
included to provide additional insight. Sessions are
expected to last approximately 30 min.
Data analysis

Given that the “think-aloud” and similar methods often
slow task completion and thought processes [21], the
focus of analysis will be on qualitative usability data via
content analysis, although a few relevant quantitative
measures will be included. Participant demographics will
be reported with descriptive statistics. Mean scores from
the SUS, the NASA-TXL, and the overall CSUQ score
and subscale scores will be calculated and reported in
addition to 95% confidence intervals. Quantitative data
from phase Ia will include time to task completion and
rate of task completion.
Audio recordings from each participant in both phase
Ia and phase Ib will be professionally transcribed. The
investigators will review the transcripts to identify
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themes and create a codebook with themes and
subthemes surrounding the usability of the ACT [32].
We will use a qualitative data analysis software program
(NVivo®) to organize and code the transcripts. We will
perform a content analysis of key themes based on the
frequency and level of emotive force expressed by participants. Themes will be examined within and across user
groups (physician anesthesiologists, CRNAs). Research
team members trained in qualitative methods will
perform the coding independently until inter-rater reliability is reached. Minor discrepancies will be resolved
through discussion and consensus. If there are major
discrepancies, we will refine the codebook and recode.
Decisions to modify components of the pilot ACT
during the usability testing will be determined by the investigative team, based on participant feedback, and will
occur in an iterative fashion.
Phase II: in situ usability and feasibility testing
Participants

Participants will include groups of clinicians who would
be eligible to staff the ACT (ACTors), namely attending
anesthesiologists and anesthesiology residents, who will
be recruited via email. Over the course of this phase, we
expect to include 10 subjects [24, 25]. Subjects who
complete phase Ia or phase Ib will be eligible to participate in phase II. Resident physicians will participate for
ten consecutive business days, due to scheduling constraints at our institution. Attending anesthesiologists
will participate one business day at a time and may
participate more than once.
Procedure

During the sessions, ACTors will use several different software programs to remotely monitor active operating room
locations in real time. No research staff will be present.
Orientation videos and documents will be provided to participants. They will address alerts that are created within
AW Tower Mode (see Appendix 1), but they will not
interact with CORs. Other than the lack of interaction between ACTors and CORs, this testing involves a functional
prototype of AW Tower Mode and live software programs.
A log of all alerts and ACTor responses, including ACTor
comments on individual alerts and the documented level
of significance for each alert, will be automatically generated and stored on a secure server.
All participants will complete the aforementioned 10item System Usability Scale (SUS [29]), the 19-item
Computer System Usability Questionnaire (CSUQ [30]),
and the NASA Task Load Index (NASA-TLX [26]). Resident physicians will complete these scales on days 1, 5,
and 10. Attending physicians will complete these scales
each day that they are in the ACT. In addition, ACTors
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will have the opportunity to provide written feedback on
a daily basis.
Data analysis

This phase of in situ testing will allow us to further
evaluate the usability of the ACT and the feasibility of
implementation. Demographics will be included with
descriptive statistics. Mean scores and 95% confidence
intervals for the SUS, the NASA-TXL, and the CSUQ
scale and subscale will be calculated and reported for
assessment of subjective satisfaction and usability. Any
written feedback from participants will be coded using
standard techniques for analyzing qualitative data [33].
The feasibility of implementing the ACT will also be examined through analysis of AW data logs for measures
of effectiveness and efficiency in this near real-world
setting [15, 17, 19, 34–36]. Effectiveness, or the degree
to which users are able to succeed in achieving their
goals [20], can be described as the “accuracy and completeness” with which tasks are accomplished [34].
Methods of assessing effectiveness include evaluating the
quantity and quality of task completion [17, 34]. In this
phase of in situ testing, we will assess effectiveness by
examining data such as the number of alerts that are
successfully addressed and the number of patients that
are evaluated. We will also evaluate some measures of
efficiency such as the rate at which alerts are addressed,
rate of missed alerts, and number of errors.
Patterns in alert responses will also be analyzed.
Learnability as part of a feasibility assessment will be
determined by evaluating changes in performance of
ACTors across levels of experience. The usefulness of
individual alerts will be determined by the frequency
with which they are rated as significant or insignificant.
Changes to the ACT based on information obtained
throughout this phase, including the revision of AW
alerts, will be made based on the judgment of the investigative team.

Discussion
Many barriers exist to the implementation of novel
health information technologies. Thorough and continual evaluation of the usability of such technologies is
critical. A variety of approaches to usability assessment
have been employed. These include cognitive walkthrough methods [37], focus groups [16], surveys [38],
and “think-aloud” protocol analysis [37, 39–42]. A combination of methods is often more powerful than single
methods in isolation [43]. Furthermore, “near-live” testing often discover concerns that would have otherwise
been missed and is important in the evaluation of the
feasibility of implementing a new technology [39, 44].
Therefore, in this protocol, we employ a combination of
formal and real-world mixed-methods usability testing.
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The formal think-aloud usability sessions with two
groups of end users in phase I will provide rich information on surface-level usability problems actually encountered by these users [37]. This data will inform the
development and refinement of the ACT intervention,
particularly in the early phases of design and implementation. “Think-aloud” testing is well suited to identify
barriers to adoption for new technologies [12], although
limitations of this method include the potential for
hindering cognitive processes, particularly for tasks that
involve a high cognitive load [45]. We anticipate that the
phase II in situ qualitative and quantitative usability testing, with its heightened fidelity, will provide additional
and complementary insight into usability and workflow
concerns in a more realistic setting. Real-world testing
such as this often discovers concerns that would have
otherwise been missed in exploratory or formal usability
testing [39, 44]. By analyzing a combination of data logs
and user questionnaires, we will obtain results pertaining
to major usability elements, namely, efficacy, efficiency,
learnability, and satisfaction [20, 22, 35, 43, 46], that will
allow us to ensure a useful and usable resource for our
clinicians.
Usability testing throughout the lifecycle of a given
technology is a crucial component of the successful
implementation of such technologies [36, 43], and the
results of our iterative analyses will inform and refine
the development of our intervention, particularly the
AW Tower Mode platform. This Tower Mode platform
is a customized product being specifically created and
designed for the purpose of instituting the ACT and for
our future randomized controlled trial. Although we are
testing with a limited sample size, we anticipate that the
results of the usability analysis described in this paper
will provide a sufficient breadth and depth of information to allow us to ensure that the platform, which plays
an integral role in the ACT, incorporates the actual
needs of our users [24].
The planned pragmatic RCT will continue to evaluate
user experience in real-world implementation settings to
capture additional information about usability. For
example, the current study is designed to evaluate the
usability of the ACT and its software programs, prior to
the initiation of the randomized controlled trial in which
ACTors will be providing support to anesthesia clinicians in the OR. The usability of the modes of interaction between ACTors and CORs will not assessed
with the present methods, and we do expect this to have
an impact on the fully functional ACT. Therefore, in our
future randomized controlled trial involving the ACT
intervention, we plan to implement post-implementation
analyses [13] that evaluate and refine the ACT to ensure
that it is a useful and usable resource for our clinicians
in an actual real-world setting. We anticipate that some
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of these analyses will be in the form of surveys with both
closed and open-ended responses that are administered
to the members of the anesthesia department.
The ACTors in our study will be monitoring up to 50
patients at a time, a novel model for anesthesia care that
deviates significantly from the traditional model in
which one anesthesiologist is responsible for no more
than four rooms. The ACT will demand a high level of
cognitive functioning. This level of cognitive functioning
necessitates resources that have been thoroughly examined for design and usability flaws. Thus, this series of
iterative usability testing and improvement is vital to the
development and implementation of our innovative
intervention.

Appendix 1
ACT description
ACTFAST context

The current study describes one part of our larger effort
to implement the Anesthesiology Control Tower (ACT), a
novel, telemedicine-based intervention for the operating
suite. The purpose of the research described in the current
protocol is to use iterative usability testing over the course
of approximately 6 months, in order to create a maximally
useful and usable resource for our clinicians. A second,
concurrent study by our group (Anesthesiology Control
Tower: Forecasting Algorithms to Support Treatments, or
ACTFAST2) is working to develop, refine, and validate
forecasting algorithms to predict negative patient trajectories; such algorithms will serve to help inform ACT
interventions. Our final phase of investigation will be a
yearlong comparative effectiveness randomized controlled
trial (Anesthesiology Control Tower: Feedback Alerts to
Supplement Treatments, or ACTFAST3; NCT02830126)
to demonstrate the utility of the ACT in improving adherence to clinically relevant practice guidelines and to evaluate the effect of the ACT on surrogate measures of patient
outcome. In this trial, each of our institution’s adult ORs
will be randomized on a daily basis either to a control
group or to an experimental group in which anesthesia
providers in those ORs will receive the support of the
ACT. This support will be communicated in the form of
additional alerts sent by the physicians in the ACT, whose
responsibility is to filter and prioritize information, thus
maximizing alert quality and minimizing false alarms.
ACT technology

One of the key components of the ACT technological infrastructure is an advanced clinical monitoring and display
system called AlertWatch ® (Ann Arbor, MI). AlertWatch
(AW) uses a multi-threaded Java-based server to collect
and integrate clinical information from multiple distinct
data sources for presentation in a simplified and intuitive
manner (see Figs. 1, 2 and 3). AW provides alerts based
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Fig. 1 AlertWatch Tower Mode census view. From this view, clinicians in the ACT can obtain a brief overview of all the patients in the ORs. Alerts
and abnormal physiologic and laboratory parameters are represented by squares and triangles, respectively; checkmarks indicate alerts that must
be addressed by the ACT. These groups of alerts are unique to the AW Tower Mode and will be refined based on the results of the present study.
Clicking on an OR accesses the detailed information for that OR

on its continual analysis of the current patient state; when
patient parameters fall outside of predetermined set
points, AW triggers written and auditory alarms within
the patient display and on the census view. The AW
Tower Mode platform used in this study is distinct from
the commercially available product in many ways and will
be refined based on the results of the present study.
AlertWatch and all additional electronic records used
by our hospital are available via secure Internet connection to clinicians at any physical location in the world,

allowing for the creation of our remote ACT. This includes our anesthesia information management system,
MetaVision (iMDsoft®, Needham, MA; Centricity, General Electric Healthcare), which contains both manually
entered data and automatically recorded physiologic data
for the perioperative period.
ACT structure

The ACT is physically housed within the hospital complex
and is remoted from the physical operating rooms. This

Fig. 2 AlertWatch Tower Mode patient display. Organ systems are depicted and labeled with relevant physiologic variables and values. Colors
outlining organs indicate normal (green), marginal (yellow), or abnormal function (red). The left side of the display shows patient characteristics
and case information. Information regarding the actual patient’s comorbidities can be accessed by selecting the organ system or laboratory study
of interest. Text alerts are present on the right-hand side of the screen. The black checkmark at the bottom of the left panel indicates that there
is an active alert for the ACT clinicians to address; clicking on the checkmark opens the case review dialogue (Figure 3)
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Fig. 3 Case review. This popup window allows physicians in the ACT (ACTors) to document their assessment of alerts and what actions they
would recommend. This is a feature of AlertWatch that is unique to the ACT Tower Mode platform. ACTors successfully assess and address an
alert by documenting their assessment of the significance of the alert and by documenting what action they would recommend taking, if any

room includes three computers: two with two monitors
and one with three monitors (one being a flat panel TV
screen). An additional flat panel TV screen is powered by
the third computer. The presence of additional monitors
allows multiple AW windows to be visible, in addition to
providing space for the separate, necessary software programs that will be needed. All software (i.e., our electronic
medical record, our anesthesia information management
system, and AW) either is accessible on these computers
through desktop icons or links through our department’s
webpage. A guide to the ACT and an AW help guide are
provided in a physical format in addition to electronic
copies. Two landline telephones and one iPhone will be
available in the randomized control trial.
The ACT will be staffed by attending anesthesiologists
and anesthesiology residents who are in their final year
of training. The main role of these trained clinicians
(referred to as “ACTors”) is to monitor all active ORs by
making use of AlertWatch, the hospital’s EMR, and
the anesthesiology information management system.
ACTors will assess and address alerts within the AW
Tower Mode platform (Figure 3) and will use their
clinical judgment to determine whether a particular
alert warrants contact with the clinicians in the OR
(CORs) to provide additional support.

Appendix 2
Debriefing scripts
Debriefing script for phase Ia (ACTor sessions)

Thank you for filling out the questionnaires. Before you
leave, I would love to talk briefly about your overall
impression of the ACT.
Right now how do you feel about the ACT after the
session today?
Were there problems that you encountered with any of
the software?

Were there problems that you encountered with the
physical set up?
Was there anything in the AlertWatch program or the
other software that you think worked well?
Was there anything in the physical set up of the ACT
that you think worked well?

Debriefing script for phase Ib (COR sessions)

For each case scenario:
What thoughts come to your mind as you imagine this
[scenario]?
Would you want to communicate with the ACT? If so,
what would you communicate?
Do you think the ACT would be helpful in this
situation?
If yes, what makes it helpful?
If not, what keeps it from being helpful?
Could it ever be helpful?
For the final debriefing:
Now that we are finished with that part [of the
session], do you have additional general thoughts about
the ACT?
What are instances in which you think it would be
beneficial to receive an alert or assistance from the
ACT?
If participant cannot think of instances, prompt
further: is there any clinical situation that you can think
of in which it would be helpful to receive alerts from the
ACT?
What are instances in which it would be not be
beneficial or helpful to receive an alert?
What form of alert, phone call, text, or page, would be
most helpful? Would that ever change?
Do you have any other feedback, concerns, or questions
before we end?
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Control Tower; AW: AlertWatch; COR: Clinician in the operating room;
CRNA: Certified registered nurse anesthetist; CSUQ: Computer System
Usability Questionnaire; IT: Information technology; NASA-TLX: NASA Task
Loading Index; OR: Operating room; SUS: System Usability Scale

Page 8 of 9

8.

9.

10.
Funding
This protocol has not received any specific grants from funding agencies.
The pilot study has received grant support from the Washington University
Institute of Clinical and Translational Sciences Clinical and Translational
Research Funding Program (award #4265). It has also received support from
the Agency for Healthcare and Research Quality in preparation for the
randomized controlled trial (R21 HS024581-01A1).

11.
12.

13.
Availability of data and materials
Not applicable.
14.
Authors’ contributions
TM-T was responsible for the study conception and design and drafted the
manuscript as lead writer, along with MP. FW, MB, and MA contributed to
the study design and made critical revisions to the paper. All authors read
and approved the final manuscript.
Ethics approval
Approval for this protocol was obtained from the Washington University
Institutional Review Board (IRB #201611035).

15.

16.
17.

18.

Consent for publication
Not applicable.

19.

Competing interests
The authors declare that they have no competing interests.

20.

Publisher’s Note

21.
22.

Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

23.

Author details
1
Department of Anesthesiology, Washington University School of Medicine,
660 Euclid Ave, Camps Box 8054, St. Louis, MO 63110, USA. 2Washington
University School of Medicine, 660 Euclid Ave, St. Louis, MO 63110, USA.
3
Department of Surgery, Washington University School of Medicine, 600
Euclid Ave, St. Louis, MO 63110, USA. 4Washington University School of
Public Health, 600 Euclid Ave, St. Louis, MO 63110, USA.

24.
25.
26.
27.

Received: 15 March 2017 Accepted: 15 January 2018
28.
References
1. Lee TH, et al. Derivation and prospective validation of a simple index for
prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;
100(10):1043–9.
2. Turrentine FE, et al. Surgical risk factors, morbidity, and mortality in elderly
patients. J Am Coll Surg. 2006;203(6):865–77.
3. Bilimoria KY, et al. Development and evaluation of the universal ACS NSQIP
surgical risk calculator: a decision aid and informed consent tool for
patients and surgeons. J Am Coll Surg. 2013;217(5):833-42.e1-3.
4. Kheterpal S, et al. Predictors of postoperative acute renal failure after
noncardiac surgery in patients with previously normal renal function.
Anesthesiology. 2007;107(6):892–902.
5. Aronson S, et al. Intraoperative systolic blood pressure variability predicts
30-day mortality in aortocoronary bypass surgery patients. Anesthesiology.
2010;113(2):305–12.
6. Biccard BM, Rodseth RN. What evidence is there for intraoperative
predictors of perioperative cardiac outcomes? A systematic review. Perioper
Med (Lond). 2013;2(1):14.
7. Walsh M, et al. Relationship between intraoperative mean arterial pressure
and clinical outcomes after noncardiac surgery: toward an empirical
definition of hypotension. Anesthesiology. 2013;119(3):507–15.

29.
30.

31.
32.
33.
34.
35.
36.
37.

Nair BG, et al. Anesthesia information management system-based near realtime decision support to manage intraoperative hypotension and
hypertension. Anesth Analg. 2014;118(1):206–14.
Lipton JA, et al. Impact of an alerting clinical decision support system for
glucose control on protocol compliance and glycemic control in the
intensive cardiac care unit. Diabetes Technol Ther. 2011;13(3):343–9.
Sathishkumar S, et al. Behavioral modification of intraoperative
hyperglycemia management with a novel real-time audiovisual monitor.
Anesthesiology. 2015;123(1):29037.
Morris AH, Hirshberg E, Sward KA. Computer protocols: how to implement.
Best Pract Res Clin Anaesthesiol. 2009;23(1):51–67.
Richardson WC, et al. Crossing the quality chasm: a new health system for
the 21st century. Washington, DC: Institute of Medicine, National Academy
Press; 2001.
The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic
hypothermia to improve the neurologic outcome after cardiac arrest. N
Engl J Med. 2002;346(8):549–56.
DesRoches CM, et al. Electronic health records in ambulatory care—a
national survey of physicians. N Engl J Med. 2008;359(1):50–60.
HIMSS Usability Task Force, Defining and Testing EMR Usability: Principles
and Proposed Methods of EMR Usability Evaluation and Rating, Healthcare
Information and Management Systems Society, Chicago, IL; 2009.
Rose AF, et al. Using qualitative studies to improve the usability of an EMR.
J Biomed Inform. 2005;38(1):51–60.
Hornbæk K. Current practice in measuring usability: challenges to usability
studies and research. International Journal of Human-Computer Studies.
2006;64(2):79–102.
Daniels J, et al. A framework for evaluating usability of clinical monitoring
technology. J Clin Monit Comput. 2007;21(5):323–30.
Zahabi M, Kaber DB, Swangnetr M. Usability and safety in electronic medical
records interface design a review of recent literature and guideline
formulation. Hum Factors. 2015;57(5):805–34.
Seffah A, et al. Usability measurement and metrics: a consolidated model.
Softw Qual J. 2006;14(2):159–78.
Rubin J. Handbook of Usability Testing. NewYork: Wiley; 1994.
Standardization, I.O.f., ISO 9241-11: ergonomic requirements for office work
with visual display terminals (VDTs): part 11: guidance on usability. 1998.
Abran A, et al. Usability meanings and interpretations in ISO standards.
Softw Qual J. 2003;11(4):325–38.
Kushniruk AW, Patel VL. Cognitive and usability engineering methods for the
evaluation of clinical information systems. J Biomed Inform. 2004;37(1):56–76.
Nielsen J. Estimating the number of subjects needed for a thinking aloud
test. International Journal of Human-Computer Studies. 1994;41:385–97.
Hart SG, Staveland LE. Development of NASA-TLX (Task Load Index): results
of empirical and theoretical research. Adv Psychol. 1988;52:139–83.
Ahmed A, et al. The effect of two different electronic health record user
interfaces on intensive care provider task load, errors of cognition, and
performance. Crit Care Med. 2011;39(7):1626–34.
Young G, Zavelina L, Hooper V. Assessment of workload using NASA Task
Load Index in perianesthesia nursing. Journal of PeriAnesthesia Nursing.
2008;23(2):102–10.
Brooke J. SUS-A quick and dirty usability scale. Usability Evaluation in
Industry. 1996;189(194):4–7.
Lewis JR. IBM computer usability satisfaction questionnaires: psychometric
evaluation and instructions for use. International Journal of HumanComputer Interaction. 1995;7(1):57–78.
Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability
scale. Intl Journal of Human–Computer Interaction. 2008;24(6):574–94.
Strauss AL, Corbin J, editors. Basics of qualitative research: grounded theory
procedures and techniques. Thousand Oaks: Sage Publications; 1990.
Patton MQ. Qualitative research & evaluation methods. Thousand Oaks:
2001 Sage Publications; 2014.
Bevan N, Macleod M. Usability measurement in context. Behav Inform
Technol. 1994;13(1–2):132–45.
Quesenbery W. Balancing the 5Es of usability. Cutter IT Journal. 2004;
17(2):4–11.
Yen PY, Bakken S. Review of health information technology usability study
methodologies. J Am Med Inform Assoc. 2012;19(3):413–22.
Jaspers MW. A comparison of usability methods for testing interactive
health technologies: methodological aspects and empirical evidence. Int J
Med Inform. 2009;78(5):340–53.

Murray-Torres et al. Pilot and Feasibility Studies (2018) 4:38

Page 9 of 9

38. Leslie SJ, et al. Clinical decision support software for management of
chronic heart failure: development and evaluation. Comput Biol Med. 2006;
36(5):495–506.
39. Li AC, et al. Integrating usability testing and think-aloud protocol analysis
with “near-live” clinical simulations in evaluating clinical decision support.
Int J Med Inform. 2012;81(11):761–72.
40. Kushniruk AW, Patel VL, Cimino JJ. Usability testing in medical informatics:
cognitive approaches to evaluation of information systems and user
interfaces. Proc AMIA Symp. 1997. p. 218–22.
41. Jaspers MW, et al. The think aloud method: a guide to user interface design.
Int J Med Inform. 2004;73(11):781–95.
42. Willis GB. Cognitive interviewing : a tool for improving questionnaire design.
Thousand Oaks: Sage Publications. xii; 2005. 335 pages.
43. Middleton B, et al. Enhancing patient safety and quality of care by
improving the usability of electronic health record systems:
recommendations from AMIA. J Am Med Inform Assoc. 2013;20(e1):e2–8.
44. Kushniruk AW, et al. Emerging approaches to usability evaluation of
health information systems: towards in-situ analysis of complex
healthcare systems and environments. Studies in Health Technology
and Informatics. 2010;169:915–9.
45. Lundgren-Laine H, Salantera S. Think-aloud technique and protocol analysis
in clinical decision-making research. Qual Health Res. 2010;20(4):565–75.
46. Zhang J, Walji MF. TURF: toward a unified framework of EHR usability. J
Biomed Inform. 2011;44(6):1056–67.

Submit your next manuscript to BioMed Central
and we will help you at every step:
• We accept pre-submission inquiries
• Our selector tool helps you to find the most relevant journal
• We provide round the clock customer support
• Convenient online submission
• Thorough peer review
• Inclusion in PubMed and all major indexing services
• Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit

